UBS maintains a 'Neutral' on Molina Healthcare (MOH); FY’11 EPS Guidance Reaffirmed Post Q3

UBS maintains a 'Neutral' on Molina Healthcare (NYSE: MOH) price target raised $1 to $19.00.

UBS analyst says, "MOH reaffirms FY’11 EPS of ~$1.55 while, as expected, mgmt discussion around 2012 to wait until January investor day where mgmt likely to also provide update on key near-term RFPs including WA (18% of revs, contract awards in mid-Jan) and OH (21% of revs, RFP expected in Jan). Post Q3, we leave our FY’11 EPS est. at $1.55 with FY’12E EPS remaining at $1.70 as updated est now embed share repo ($75m authorization) offset by slightly more conservative MLR assumptions."

For more ratings news on Molina Healthcare click here and for the rating history of Molina Healthcare click here.

Shares of Molina Healthcare closed at $18.32 yesterday.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Viking Holdings (VIK) PT Raised to $82 at Mizuho
• Beike (BEKE) PT Raised to $23 at Morgan Stanley
• Benchmark Reiterates Buy Rating on Rank One Computing (ROC)